Table A1.
Clinical-molecular characteristics from the resulting cluster analysis in Figure 3. The order of the variables is the same than in the figure.
| Clinical | Age |
| Stage | |
| Optimal treatment | |
| Optimal surgery | |
| Residual | |
| TP53 | Mutation status |
| Variant type | |
| TP53 Mutation type | |
| Gene expression | ADAM12 |
| ECM2 | |
| NUAK1 | |
| PCOLCE | |
| PMP22 | |
| RGS4 | |
| SERPINE1 | |
| Methylation | C1orf65 |
| CORO6 | |
| DDR1 | |
| FBLN7 | |
| FLJ20444 | |
| FXYD7 | |
| GALNT13 | |
| GMPR | |
| GPR157 | |
| IGFBP1 | |
| LAMC2 | |
| NFATC2 | |
| PPL | |
| RASSF5 | |
| RGPD5 | |
| RNF8 | |
| SLC1A2 | |
| SLC24A3 | |
| SLC25A39 | |
| SLC30A3 | |
| SNAI1 | |
| SPATA16 | |
| SPDEF | |
| TNFRSF18 | |
| Mutations | DNAH5 |
| MUC17 | |
| ODZ1 | |
| Copy number alteration | Chr19: 12,108,685-12,180,988 |